Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: Business Wire
Bausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma researchBausch + Lomb will also sponsor The Glaucoma Foundation’s annual month-long educational social media campaign, which spotlights stories from glaucoma patients and advocatesGlaucoma affects about four million people in the United States1 VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness Month in January. Bausch + Lomb will also sponsor The Glaucoma Foundation’s (TGF) social media campaign to raise awareness of the disease and its impact by highlighting a glaucoma patient or advocate every day in January.“Currently, about four million people in the United States are
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb CEO Brent Saunders sits down with Jim Cramer [CNBC]CNBC
- Trump says DEI, civil rights policies hurt White people. Do they? [USA TODAY]USA TODAY
- Bausch + Lomb (NYSE:BLCO) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
- Bausch + Lomb (NYSE:BLCO) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.MarketBeat
- Bausch + Lomb (NYSE:BLCO) was given a new $18.00 price target on by analysts at Evercore ISI.MarketBeat
BLCO
Earnings
- 10/29/25 - Beat
BLCO
Sec Filings
- 1/9/26 - Form 3
- 1/9/26 - Form 3
- 1/2/26 - Form 8-K
- BLCO's page on the SEC website